Drawing for CANIFERON

USPTO serial 79327653

CANIFERON

Reviewed by CopyMark Law Group

Reg. 6966132Status 700Registered
Filing date
Status date
Registration date
Jan 31, 2023
Examiner
BODRI, KRISTIN MARIE
Law office
Historical data usage

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CANIFERON?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brian M. Davis

Brian M. Davis VLP Law Group LLP5960 Fairview Rd; Suite 400Charlotte, NC 28210UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005[ Pharmaceuticals, medical and veterinary preparations for use in the treatment of skin diseases, cancer, pruritic disorders and inflammatory diseases; pharmaceutical, medical and veterinary preparations for prevention, diagnosis and treatment of skin diseases; pharmaceutical, medical and veterinary preparations for dermatitis; pharmaceutical, medical and veterinary preparations for inflammatory diseases; medicines for veterinary purposes for use in the treatment of cancer, skin disorders and inflammatory diseases; pharmaceutical, medical and ] veterinary preparations containing alpha interferon for the prevention, diagnosis and treatment of diseases and disorders, namely, cancer, dermatitis, skin diseases, * pruritic conditions, coronavirus and allergies * [ and inflammatory diseases; pharmaceutical, medical and veterinary preparations containing alpha interferon for the prevention, diagnosis and treatment of diseases and disorders, namely, cancer, dermatitis, skin diseases and inflammatory diseases, for animals; pharmaceutical, medical and veterinary drugs for use in the treatment of skin diseases, cancer, pruritic disorders and inflammatory diseases; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; biological preparations for medical use in the treatment of skin diseases, cancer, pruritic disorders and inflammatory diseases; biological reagents being pharmaceutical preparations for medical use in the treatment of skin diseases, cancer, pruritic disorders and inflammatory diseases; biological tissue cultures for medical use; biochemical preparations for medical use in the treatment of skin diseases, cancer, pruritic disorders and inflammatory diseases; anti-viral agents; diagnostic preparations for medical and veterinary purposes; clinical diagnostic reagents for medical and veterinary purposes; immunoassay reagents for medical use ]ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 21, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 13, 2025NURCNOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED—
May 1, 2025LIMELIMITATION FROM THE IB EXAMINED AND ENTERED—
Apr 24, 2025COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Apr 24, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 11, 2024LIMGLIMITATION OF GOODS RECEIVED FROM IB—
May 30, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 5, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 5, 2023FIMPFINAL DISPOSITION PROCESSED—
Apr 30, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 31, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 31, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 13, 2022DOCKASSIGNED TO EXAMINER—
Nov 15, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 15, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 26, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 11, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 4, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 3, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 3, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 19, 2022RFNTREFUSAL PROCESSED BY IB—
Jun 24, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 24, 2022RFRRREFUSAL PROCESSED BY MPU—
Jun 22, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 21, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 21, 2022DOCKASSIGNED TO EXAMINER—
Dec 14, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 10, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 9, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance